This is even more prevalent during menopause when maintaining muscle mass becomes more difficult (Nagy et al., 2025)
Results Establishment of CRC Drug-Tolerant Persister Cell Models While modeling the response to the chemotherapeutic drug 5-FU in the CRC cell line HCT116, which has exquisite sensitivity, we observed that the vast majority of the cells were killed within 9 days of exposure to the drug at a concentration 10-fold higher than the IC 50 value ( Figure 1A )
(Lausanne) 9 , 402 (2018)
Long-term Results: According to 2026 data, patients on tirzepatide or semaglutide often reach their peak weight loss between month 10 and month 14 . Total Loss: Most successful patients see a total reduction of 15% to 22% of their starting weight by the one-year mark. The Shift: At this stage, you and your doctor will discuss whether to stay on a "maintenance" dose or begin a very slow taper, depending on your metabolic health goals
Where your body just doesnt seem to burn fuel the way it once did even when youre eating right and moving regularly
Some folks like bodybuilders and athletes report enhanced muscle mass and strength